apl. Prof. Dr. Markus Heppt



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Comparative efficacy analysis identifies immune checkpoint blockade as a new survival benchmark in advanced cutaneous squamous cell carcinoma (2022) Petzold A, Steeb T, Wessely A, Schatton T, Berking C, Heppt M Journal article Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies (2022) Kaiser I, Mathes S, Pfahlberg AB, Uter W, Berking C, Heppt M, Steeb T, et al. Journal article Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma (2022) Wendlinger S, Wohlfarth J, Kreft S, Siedel C, Kilian T, Dischinger U, Heppt M, et al. Journal article Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement (2022) Breakell T, Waibel H, Schliep S, Ferstl B, Erdmann M, Berking C, Heppt M Journal article Explainable artificial intelligence in skin cancer recognition: A systematic review (2022) Hauser K, Kurz A, Haggenmüller S, Maron RC, von Kalle C, Utikal JS, Meier F, et al. Journal article, Review article Genetic characterization of advanced conjunctival melanoma and response to systemic treatment (2022) Lodde GC, Jansen P, Möller I, Sucker A, Hassel JC, Forschner A, Eckardt J, et al. Journal article Annual Health Care Utilization and Costs for Treatment of Cutaneous and Anogenital Warts Among a Commercially Insured Population in the US, 2017-2019 Reply (2022) Heppt M, Steeb T, Berking C Journal article, Letter Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (2022) Heppt M, Dykukha I, Graziadio S, Salido-Vallejo R, Chapman-Rounds M, Edwards M Journal article, Review article Reporting Quality of Studies Developing and Validating Melanoma Prediction Models: An Assessment Based on the TRIPOD Statement (2022) Kaiser I, Diehl K, Heppt M, Mathes S, Pfahlberg AB, Steeb T, Uter W, Gefeller O Journal article Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity (2022) Koch E, Petzold A, Wessely A, Dippel E, Gesierich A, Gutzmer R, Hassel JC, et al. Journal article